CCDC 858020: Experimental Crystal Structure Determination
Antonia F. Stepan(Pfizer (United States)), Christopher J. O’Donnell(Pfizer (United States)), David Riddell(Eli Lilly (United States)), T.J. O'Sullivan, C.E. Oborski, Sven Becker(Laboratoire National Henri Becquerel), Bethany L. Kormos(Pfizer (United States)), P.H. Dorff, Leslie R. Pustilnik(Pfizer (United States)), Chakrapani Subramanyam(Pfizer (United States)), Kenneth J. DiRico(Pfizer (United States)), S.H. Capetta(Pfizer (United States)), Kevin Atchison(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ashley Robshaw(Pfizer (United States)), Khadga Jung Karki, Brian T. Sneed, Walter S. McDonald, C.E. Nolan, Liming Zhang(University of California System), Michael E. Green(Pfizer (United States)), Ivan Efremov(Pfizer (United States)), G.W. Kauffman, Amy Won, Yasong Lu(Pfizer (United States)), A.J. Hallgren(Pfizer (United States)), J.K. Dutra, E. Sibley(Pfizer (United States))
Cited by 0
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
A Non-Diazo Approach to α-Oxo Gold Carbenes via Gold-Catalyzed Alkyne Oxidation
|Accounts of Chemical Research|2014|677
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
|Nature Medicine|2020|445
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351